Skip to main content
. 2016 Jul 6;14(3):1923–1932. doi: 10.3892/mmr.2016.5474

Figure 2.

Figure 2

Comparison of LOXL2 mRNA expression levels in hepatocellular carcinoma cell lines treated with LOXL2-siRNA and controls. **P<0.01 vs. control. LOXL2, lysyl oxidase-like 2; siRNA, small interfering RNA.